Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN - Module II

Sep 24, 2024

- Sep 23, 2025

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

This course is available for logged in users only. Please login or register to take the course.

Obstructive Hypertrophic Cardiomyopathy: Evidence-Based, Specific Pathology-Targeted Manag...

LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”

MANAGEMENT OF PSVT: UPDATE FROM ACC25